Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities

被引:36
作者
Jang, YJ [1 ]
Park, KS
Chung, HY
Kim, HI
机构
[1] Ajou Univ, Sch Med, Inst Med Sci, Immunol Lab, Suwon 442721, South Korea
[2] Ajou Univ, Sch Med, Dept Microbiol, Suwon 442721, South Korea
[3] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea
关键词
TRAIL; tumor; apoptosis; Jurkat; DR5; caspase-8; caspase-3; RIP;
D O I
10.1016/S0304-3835(02)00680-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to exert potent cytotoxic activity against many tumor cells but not normal cells. However, some tumor cells are resistant to TRAIL, and it has not been determined how this occurs. In the present study, we obtained three subgroups of Jurkat clones with TRAIL-sensitive, -partial resistant and resistant phenotypes. We found that most TRAIL-resistant and -partial resistant clones expressed low levels of DR5, whereas most TRAIL-sensitive clones expressed high levels of Death Receptor (DR5). However, there were clones with a range of different TRAIL-sensitivities that had similar levels of DR5 expression. The expression levels of DR4 and the decoy receptors, DcR1 and DcR2, did not correlate with TRAIL sensitivities. We also compared the subgroups in terms of the expression of Fas-associated death domain protein (FADD), the levels of activation of Receptor Interacting Protein (RIP) and caspases, and cleavage of Poly (ADP-Ribose)Polymerase (PARP). Basal expression levels of FADD were not significantly different among the subgroups. After treatment with TRAIL, both TRAIL-sensitive and partial resistant clones showed high levels of activation of caspase-3, caspase-8, RIP and PARP. Relative basal level and induced level of Phosphoprotein over Expressed in Diabetes/Phosphoprotein Enriched in Astrocytes (PED/PEA-15) after TRAIL treatment were compared in the clones. Basal levels of PED/PEA-15 expression were similar among sensitive, partial resistant and resistant clones. TRAIL did not change the PED/PEA-15 level in the clones. In addition, transduction and expression of the dominant negative form of the I-k Balpha gene did not change TRAIL-sensitivities. Our results showed that the expression levels of DR5, the activation levels of caspase-8, -3 and RIP were critical factors in determining TRAIL-sensitivities in Jurkat cells. The results of our study also suggest that cells with different TRAIL-sensitivities arise through multiple mechanisms even within a single cell line. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:107 / 117
页数:11
相关论文
共 56 条
  • [1] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [2] NF-kappa B: Ten years after
    Baeuerle, PA
    Baltimore, D
    [J]. CELL, 1996, 87 (01) : 13 - 20
  • [3] TRAIL receptor-2 signals apoptosis through FADD and caspase-8
    Bodmer, JL
    Holler, N
    Reynard, S
    Vinciguerra, P
    Schneider, P
    Juo, P
    Blenis, J
    Tschopp, J
    [J]. NATURE CELL BIOLOGY, 2000, 2 (04) : 241 - 243
  • [4] BROCKMAN JA, 1996, CELL, V87, P13
  • [5] CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION
    BROWN, K
    GERSTBERGER, S
    CARLSON, L
    FRANZOSO, G
    SIEBENLIST, U
    [J]. SCIENCE, 1995, 267 (5203) : 1485 - 1488
  • [6] Caspases: the executioners of apoptosis
    Cohen, GM
    [J]. BIOCHEMICAL JOURNAL, 1997, 326 : 1 - 16
  • [7] PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus
    Condorelli, G
    Vigliotta, G
    Iavarone, C
    Caruso, M
    Tocchetti, CG
    Andreozzi, F
    Cafieri, A
    Tecce, MF
    Formisano, P
    Beguinot, L
    Beguinot, F
    [J]. EMBO JOURNAL, 1998, 17 (14) : 3858 - 3866
  • [8] CRYNSYUAN VJ, 1997, GENE DEV, V12, P1551
  • [9] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [10] Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
    DegliEsposti, MA
    Smolak, PJ
    Walczak, H
    Waugh, J
    Huang, CP
    DuBose, RF
    Goodwin, RG
    Smith, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1165 - 1170